Serum potassium levels on admission and infarct size in patients with acute myocardial infarction.

[1]  Adnan Kastrati,et al.  Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. , 2007, Journal of the American College of Cardiology.

[2]  P. Pasdois,et al.  Sarcoplasmic ATP-sensitive potassium channel blocker HMR1098 protects the ischemic heart: implication of calcium, complex I, reactive oxygen species and mitochondrial ATP-sensitive potassium channel. , 2007, Journal of molecular and cellular cardiology.

[3]  Jun Zhu,et al.  Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.

[4]  G. Lamas,et al.  Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. , 2004, Archives of internal medicine.

[5]  A. Jaffe,et al.  The quantification of infarct size. , 2004, Journal of the American College of Cardiology.

[6]  R. Kloner,et al.  Cardiac protection during acute myocardial infarction: where do we stand in 2004? , 2004, Journal of the American College of Cardiology.

[7]  S. Nekolla,et al.  A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. , 2004, American heart journal.

[8]  Felix Zijlstra,et al.  Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. , 2003, Journal of the American College of Cardiology.

[9]  G. Gross,et al.  KATP channels and myocardial preconditioning: an update. , 2003, American journal of physiology. Heart and circulatory physiology.

[10]  E. Marbán,et al.  MCC-134, a Single Pharmacophore, Opens Surface ATP–Sensitive Potassium Channels, Blocks Mitochondrial ATP–Sensitive Potassium Channels, and Suppresses Preconditioning , 2003, Circulation.

[11]  K. Shimamoto,et al.  Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C. , 2002, Journal of the American College of Cardiology.

[12]  S. Genda,et al.  K(ATP) channel opening is an endogenous mechanism of protection against the no-reflow phenomenon but its function is compromised by hypercholesterolemia. , 2002, Journal of the American College of Cardiology.

[13]  Salim Yusuf,et al.  The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis. , 2002, Journal of the American College of Cardiology.

[14]  N. Madias,et al.  Admission serum potassium in patients with acute myocardial infarction: its correlates and value as a determinant of in-hospital outcome. , 2000, Chest.

[15]  M. Schwaiger,et al.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.

[16]  F. Eberli,et al.  ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. , 2000, Circulation.

[17]  G. Grover,et al.  ATP-Sensitive potassium channels: a review of their cardioprotective pharmacology. , 2000, Journal of molecular and cellular cardiology.

[18]  W. Schmiegel,et al.  Myocardial infarction in diabetic vs non-diabetic subjects. Survival and infarct size following therapy with sulfonylureas (glibenclamide) , 2000, European heart journal.

[19]  L. Piegas,et al.  Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .

[20]  H. Taegtmeyer,et al.  Glucose-insulin-potassium in acute myocardial infarction: the time has come for a large, prospective trial. , 1997, Circulation.

[21]  K. Beatt,et al.  Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. , 1997, Circulation.

[22]  G. Bray,et al.  A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.

[23]  P. Whincup,et al.  Serum potassium, cigarette smoking, and mortality in middle-aged men. , 1997, American journal of epidemiology.

[24]  M. Hori,et al.  Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. , 1996, Circulation.

[25]  B. Gersh,et al.  Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. , 1995, Circulation.

[26]  D. Young,et al.  Impairment of cardiac function by moderate potassium depletion. , 1995, Journal of cardiac failure.

[27]  H. Lin,et al.  Potassium's cardiovascular protective mechanisms. , 1995, The American journal of physiology.

[28]  L. Ghiadoni,et al.  Effect of potassium on vasodilation to acetylcholine in essential hypertension. , 1994, Hypertension.

[29]  L. Opie,et al.  Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias , 1994, The Lancet.

[30]  R. Narins,et al.  Hypokalemia and cardiovascular disease. , 1990, The American journal of cardiology.

[31]  T. Lüscher,et al.  High Potassium Diet Augments Endothelium‐Dependent Relaxations in the Dahl Rat , 1988, Hypertension.

[32]  R. Jennings,et al.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.

[33]  N. Kaplan,et al.  Our appropriate concern about hypokalemia. , 1984, The American journal of medicine.

[34]  E. Braunwald,et al.  Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol). , 1984, Journal of the American College of Cardiology.

[35]  R. Verrier,et al.  Influence of Glucose, Insulin, and Potassium on Vulnerability to Ventricular Fibrillation in the Canine Heart , 1978, Circulation research.

[36]  L. Opie,et al.  PROPOSED METABOLIC VICIOUS CIRCLE IN PATIENTS WITH LARGE MYOCARDIAL INFARCTS AND HIGH PLASMA-FREE-FATTY-ACID CONCENTRATIONS , 1977, The Lancet.

[37]  M. Oliver,et al.  Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. , 1968, Lancet.

[38]  A. Dorrance,et al.  A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[39]  R. Diaz,et al.  Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. , 1998, Circulation.

[40]  P. Véghelyi.  EMERGENCY HYPOTHERMIC IN MENINGOCOCCAL MENINGITIS. , 1965, Lancet.